The FDA has added a new warning to drugs including Ozempic and Wegovy, cautioning that patients taking the drugs may be at a ...

The FDA urges healthcare professionals to stop administering the products, and patients should stop using them.

Compounding pharmacies, drugmakers and the FDA share concerns about fake or subpar weight loss drugs — even though regulated compounders often get lumped together with illicit sources by the ...

The FDA’s sudden shift highlights challenges regulators and the pharmaceutical industry have faced amid unprecedented demand for the blockbuster weight-loss drugs. “The credibility of the FDA ...

While Ozempic itself is approved for the treatment of diabetes, it's often prescribed off-label to help patients shed pounds—along with its sister drug, Wegovy, and others like it that are ...

FDA Says Compounding Pharmacies ... Pharmacists may continue making compounded versions of the weight-loss medication tirzepatide while the U.S. Food and Drug Administration revisits its Oct ...

Scientists at the University of Copenhagen have discovered a new weight loss drug target that reduces appetite, increases ...

Hims & Hers Health on Wednesday launched a tracker for popular weight-loss and diabetes drugs that allows patients to share details about their challenges finding treatments such as Novo Nordisk's ...

Scientists from the University of Copenhagen say they have developed a drug that decreases appetite while increasing calorie ...

Nov. 6, 2024 – The FDA has updated the labels for all GLP-1 weight loss drugs with a warning about pulmonary aspiration ...

The FDA is warning that patients taking GLP-1s may be at a higher risk of inhaling fluid into their lungs while under ...